Back to Search
Start Over
Local production of O2- by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca2+ regulation.
- Source :
-
Cellular signalling [Cell Signal] 2008 Apr; Vol. 20 (4), pp. 637-44. Date of Electronic Publication: 2007 Dec 08. - Publication Year :
- 2008
-
Abstract
- The present study was designed to determine whether the sarcoplasmic reticulum (SR) could locally produce superoxide (O2-) via NAD(P)H oxidase (NOX) in coronary arterial myocytes (CAMs) and to address whether cADPR-RyR/Ca2+ signaling pathway regulates this local O2- production from the SR. Using confocal microscopic imaging analysis in intact single CAMs, a cell-permeable indicator CM-H2DCFDA for dynamic changes in intracellular ROS (in green color) and a highly selective ER-Tracker Red dye for tracking of the SR were found co-localized. A quantitative analysis based on the intensity of different spectra demonstrated a local O2- production derived from the SR. M(1)-receptor agonist, oxotremorine (Oxo) and a Ca2+ ionophore, A23187, time-dependently increased this O2- production colocalized with the SR. NOX inhibitors, diphenylene iodonium (DPI) and apocynin (Apo), or superoxide dismutase (SOD) and catalase, and Nox4 (a major intracellular NOX subunit) siRNA all substantially blocked this local production of O2-, demonstrating an involvement of NOX. This SR-derived O2- production was also abolished by the inhibitors of cyclic ADP-ribose (cADPR)-mediated Ca2+ signaling, such as nicotinamide (Nicot, 6 mM), ryanodine (Rya, 50 muM) or 8-Br-cADPR (30 microM). However, IP3 antagonist, 2-APB (50 microM) had no effect. In CAMs transfected with siRNA of ADP-ribosyl cyclase or RyR, this SR O2- production was attenuated. Electron spin resonance (ESR) spectromic assay in purified SR also demonstrated the production of O2- that was dependent on NOX activity and Ca2+ concentrations. These results provide direct evidence that O2- could be locally produced via NOX on the SR and that this local O2- producing system is controlled by cADPR-RyR/Ca2+ signaling pathway.
- Subjects :
- ADP-ribosyl Cyclase antagonists & inhibitors
ADP-ribosyl Cyclase genetics
ADP-ribosyl Cyclase metabolism
Acetophenones pharmacology
Animals
Calcimycin pharmacology
Calcium metabolism
Catalase metabolism
Cattle
Cells, Cultured
Coronary Vessels enzymology
Coronary Vessels metabolism
Cyclic ADP-Ribose analogs & derivatives
Cyclic ADP-Ribose antagonists & inhibitors
Cyclic ADP-Ribose pharmacology
Electron Spin Resonance Spectroscopy
Enzyme Inhibitors pharmacology
Ionophores pharmacology
Microscopy, Confocal
Muscarinic Agonists pharmacology
Muscle, Smooth, Vascular drug effects
Muscle, Smooth, Vascular enzymology
Myocytes, Smooth Muscle drug effects
Myocytes, Smooth Muscle enzymology
NADPH Oxidases antagonists & inhibitors
NADPH Oxidases genetics
Niacinamide pharmacology
Onium Compounds pharmacology
Oxotremorine pharmacology
RNA Interference
RNA, Small Interfering metabolism
Receptor, Muscarinic M1 agonists
Receptor, Muscarinic M1 metabolism
Ryanodine pharmacology
Ryanodine Receptor Calcium Release Channel genetics
Ryanodine Receptor Calcium Release Channel metabolism
Sarcoplasmic Reticulum drug effects
Sarcoplasmic Reticulum enzymology
Superoxide Dismutase metabolism
Time Factors
Calcium Signaling drug effects
Cyclic ADP-Ribose metabolism
Muscle, Smooth, Vascular metabolism
Myocytes, Smooth Muscle metabolism
NADPH Oxidases metabolism
Sarcoplasmic Reticulum metabolism
Superoxides metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0898-6568
- Volume :
- 20
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cellular signalling
- Publication Type :
- Academic Journal
- Accession number :
- 18207366
- Full Text :
- https://doi.org/10.1016/j.cellsig.2007.11.013